Eli Lilly & Co.
Returns on Capital
| Fiscal Year | ROE | ROI | ROA |
|---|---|---|---|
| FY2021 | 62.2% | 22.9% | 11.4% |
| FY2022 | 58.6% | 24.6% | 12.6% |
| FY2023 | 48.6% | 18.0% | 8.2% |
| FY2024 | 74.2% | 24.7% | 13.5% |
| FY2025 | 77.8% | 30.6% | 18.4% |
Returns on Capital
| Fiscal Year | ROE | ROI | ROA |
|---|---|---|---|
| FY2021 | 62.2% | 22.9% | 11.4% |
| FY2022 | 58.6% | 24.6% | 12.6% |
| FY2023 | 48.6% | 18.0% | 8.2% |
| FY2024 | 74.2% | 24.7% | 13.5% |
| FY2025 | 77.8% | 30.6% | 18.4% |